EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer

被引:0
|
作者
Roderich E. Schwarz
Niranjan Awasthi
Srivani Konduri
Danielle Cafasso
Margaret A. Schwarz
机构
[1] UT Southwestern Medical Center,Department of Surgery, Division of Surgical Oncology
[2] UT Southwestern Medical Center,Department of Pediatrics, Division of Pediatric Critical Care Medicine
[3] The Cancer Institute of New Jersey,Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Divisions of Surgical Oncology and Surgical Sciences
来源
关键词
Vascular Endothelial Growth Factor; Proliferate Cell Nuclear Antigen; PDAC Cell; ASPC Cell; Tumor Tissue Section;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1442 / 1452
页数:10
相关论文
共 50 条
  • [41] Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer
    Awasthi, Niranjan
    Zhang, Changhua
    Ruan, Winston
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    PLOS ONE, 2012, 7 (06):
  • [42] Androgen receptor blockade in experimental combination therapy of pancreatic cancer
    Konduri, Srivani
    Schwarz, Margaret A.
    Cafasso, Danielle
    Schwarz, Roderich E.
    JOURNAL OF SURGICAL RESEARCH, 2007, 142 (02) : 378 - 386
  • [43] CASP1 is a target for combination therapy in pancreatic cancer
    Wang, Xianfeng
    Chen, Zheng
    Nie, Dingrui
    Zeng, Xiangbo
    Zhong, Mengjun
    Liu, Xin
    Zhong, Shuxin
    Wang, Liang
    Liao, Ziwei
    Chen, Cunte
    Li, Yangqiu
    Zeng, Chengwu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [44] Combination therapy with Oxaliplatin plus Gemcitabine in advanced pancreatic cancer
    Klapdor, R
    Martini-Svendsen, J
    Seutter, R
    Fenner, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S146 - S146
  • [45] In Silico Design and Experimental Validation of Combination Therapy for Pancreatic Cancer
    Vundavilli, Haswanth
    Datta, Aniruddha
    Sima, Chao
    Hua, Jianping
    Lopes, Rosana
    Bittner, Michael
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2020, 17 (03) : 1010 - 1018
  • [46] Pancreatic Cancer: Utility of Dynamic Contrast-enhanced MR Imaging in Assessment of Antiangiogenic Therapy
    Akisik, M. Fatih
    Sandrasegaran, Kumaresan
    Bu, Guixue
    Lin, Chen
    Hutchins, Gary D.
    Chiorean, Elena G.
    RADIOLOGY, 2010, 256 (02) : 441 - 449
  • [47] Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
    Lingyue Liu
    Xing Huang
    Fukang Shi
    Jinyuan Song
    Chengxiang Guo
    Jiaqi Yang
    Tingbo Liang
    Xueli Bai
    Journal of Experimental & Clinical Cancer Research, 41
  • [48] Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
    Liu, Lingyue
    Huang, Xing
    Shi, Fukang
    Song, Jinyuan
    Guo, Chengxiang
    Yang, Jiaqi
    Liang, Tingbo
    Bai, Xueli
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [49] PANCREATIC CANCER THERAPY BASED ON COMBINATION OF DNA VACCINATION AND PI3KGAMMA INHIBITION
    Novelli, Francesco
    Curcio, Claudia
    Roux, Cecilia
    Conti, Laura
    Curto, Roberta
    Mucciolo, Gianluca
    Bulfamante, Sara
    Brugiapaglia, Silvia
    Scagliotti, Alessandro
    Ghigo, Alessandra
    Cappello, Paola
    Hirsch, Emilio
    Novelli, Francesco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A288 - A288
  • [50] Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Zhang, Changhua
    Klinz, Stephan G.
    Meyer-Losic, Florence
    Beaufils, Benjamin
    Thiagalingam, Arunthathi
    Schwarz, Roderich E.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (07) : 1149 - 1159